Dexamethasone ophthalmic and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Dexamethasone ophthalmic and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexamethasone ophthalmic
Brand name: Dextenza, Dexycu, Ozurdex, Maxidex
Synonyms: Dexamethasone (intraocular), Dexamethasone (Ophthalmic)
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexamethasone ophthalmic-Insulin degludec
- Dexamethasone ophthalmic-Insulin Degludec (U-100) Prefilled Pens
- Dexamethasone ophthalmic-Insulin Degludec (U-100) Vials
- Dexamethasone ophthalmic-Insulin Degludec (U-200) Prefilled Pens
- Dexamethasone ophthalmic-Insulin degludec and liraglutide
- Dexamethasone ophthalmic-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Dexamethasone Oral Drops
- Insulin aspart, recombinant Subcutaneous-Dexamethasone SodiumPhosphate
- Insulin aspart, recombinant Subcutaneous-Dexamethasone Solution (Drops)
- Insulin aspart, recombinant Subcutaneous-Dexamethasone Tablets
- Insulin aspart, recombinant Subcutaneous-Dexamethasone, neomycin, and polymyxin B ophthalmic
- Insulin aspart, recombinant Subcutaneous-Dexasone injection